Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5L72

PI3 kinase delta in complex with N-[6-(5-methanesulfonamido-6-methoxypyridin-3-yl)-1,3-dihydro-2-benzofuran-4-yl]-2-(morpholin-4-yl)acetamide

5L72 の概要
エントリーDOI10.2210/pdb5l72/pdb
分子名称Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, N-[6-(5-methanesulfonamido-6-methoxypyridin-3-yl)-1,3-dihydro-2-benzofuran-4-yl]-2-(morpholin-4-yl)acetamide (3 entities in total)
機能のキーワードpi3 kinase delta, transferase
由来する生物種Mus musculus (Mouse)
タンパク質・核酸の鎖数1
化学式量合計108284.17
構造登録者
Rowland, P. (登録日: 2016-06-01, 公開日: 2016-07-27, 最終更新日: 2024-06-19)
主引用文献Amour, A.,Barton, N.,Cooper, A.W.,Inglis, G.,Jamieson, C.,Luscombe, C.N.,Morrell, J.,Peace, S.,Perez, D.,Rowland, P.,Tame, C.,Uddin, S.,Vitulli, G.,Wellaway, N.
Evolution of a Novel, Orally Bioavailable Series of PI3K delta Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease.
J.Med.Chem., 59:7239-7251, 2016
Cited by
PubMed Abstract: A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics.
PubMed: 27429068
DOI: 10.1021/acs.jmedchem.6b00799
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.06 Å)
構造検証レポート
Validation report summary of 5l72
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon